入院时淋巴细胞减少可预测创伤性脑损伤患者的感染并发症与死亡
这是一项10年回顾性研究,纳入2570例头部AIS 2-6分且入院24小时内采集绝对淋巴细胞计数(ALC)的TBI患者,排除入院24小时内死亡及入院时肠穿孔者。946例(36.8%)入院ALC≤1000(淋巴细胞减少组)。淋巴细胞减少与死亡风险增加(OR=1.903 [1.389-2.608];P<0.001)、肺炎风险增加(OR=1.510 [1.081-2.111];P=0.016)、住院时间延长(OR=1.337 [1.217-1.469];P<0.001)、出院时需额外医疗资源(OR=1.669 [1.344-2.073];P<0.001)及早期院内死亡风险增加(OR=1.459 [1.097-1.941];P=0.009)相关。亚组分析显示,在多发伤及两种或以上并发TBI类型的患者中,淋巴细胞减少与死亡相关;所有亚组分析中,淋巴细胞减少均与住院时间延长及出院需更高水平照护相关。结论认为对所有TBI患者进行常规全血细胞计数及分类可能有助于预测结局并指导治疗。
要点
- TBI患者入院24小时内ALC≤1000(淋巴细胞减少)者死亡风险增加:OR=1.903 [1.389-2.608];P<0.001。
- 淋巴细胞减少组肺炎风险增加:OR=1.510 [1.081-2.111];P=0.016。
- 淋巴细胞减少组住院时间延长:OR=1.337 [1.217-1.469];P<0.001;出院需额外医疗资源:OR=1.669 [1.344-2.073];P<0.001。
- 淋巴细胞减少组早期院内死亡风险增加:OR=1.459 [1.097-1.941];P=0.009。
- 亚组分析中,多发伤及两种或以上并发TBI类型患者,淋巴细胞减少与死亡相关;所有亚组均与住院时间延长及出院需更高水平照护相关。
适用人群与场景
- 头部简明损伤定级(AIS)2至6分、入院24小时内采集绝对淋巴细胞计数(ALC)的TBI患者。
- 排除入院24小时内死亡者及入院时存在肠穿孔者。
诊断标准与关键阈值
- 淋巴细胞减少定义为入院24小时内ALC≤1000(原文单位未注明)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:10年回顾性综述;样本量2570例;单中心(原文未明确中心数,从设计推断为单中心回顾性研究)。
- 人群:TBI患者,头部AIS 2-6分,入院24小时内采集ALC;排除入院24小时内死亡及入院时肠穿孔者。
- 暴露:入院ALC≤1000(淋巴细胞减少组,n=946,36.8%)vs 非淋巴细胞减少组。
- 主要终点结果:淋巴细胞减少与死亡风险增加相关(OR=1.903 [1.389-2.608];P<0.001)。
- 关键次要终点:肺炎(OR=1.510 [1.081-2.111];P=0.016)、住院时间延长(OR=1.337 [1.217-1.469];P<0.001)、出院需额外医疗资源(OR=1.669 [1.344-2.073];P<0.001)、早期院内死亡(OR=1.459 [1.097-1.941];P=0.009)。
- 亚组分析:多发伤及两种或以上并发TBI类型患者中,淋巴细胞减少与死亡相关;所有亚组中淋巴细胞减少均与住院时间延长及出院需更高水平照护相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究(10年回顾性综述)。
- 证据等级或推荐强度:原文未提及。
- 局限:回顾性设计、单中心(原文未明确中心数,从设计推断为单中心)、观察性研究不能证明因果关系;淋巴细胞减少组年龄更大且合并症更多(心力衰竭、高血压、慢性肾脏病),可能存在混杂;原文未提及多因素校正情况。
对床旁实践的改变
- 对符合纳入标准的TBI患者(头部AIS 2-6分、入院24小时内),常规全血细胞计数及分类可提供ALC信息,ALC≤1000提示死亡、肺炎、住院延长及出院需更高照护风险增加,可辅助风险分层。
- 不适用于入院24小时内死亡或入院时肠穿孔的TBI患者(原文排除人群)。
- 淋巴细胞减少组年龄更大、合并心力衰竭/高血压/慢性肾脏病比例更高,判读ALC时应考虑这些基线差异,避免将相关性误作因果。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury (TBI) is a major cause of mortality and disability associated with increased risk of secondary infections. Identifying a readily available biomarker may help direct TBI patient care. Herein, we evaluated whether admission lymphopenia could predict outcomes of TBI patients.
METHODS: This is a 10-year retrospective review of TBI patients with a head Abbreviated Injury Score 2 to 6 and absolute lymphocyte counts (ALC) collected within 24 h of admission. Exclusion criteria were death within 24 h of admission and presence of bowel perforation on admission. Demographics, admission data, injury severity score, mechanism of injury, and outcomes were collected. Association between baseline variables and outcomes was analyzed.
RESULTS: We included 2,570 patients; 946 (36.8%) presented an ALC ≤1,000 on admission (lymphopenic group). Lymphopenic patients were significantly older, less likely to smoke, and more likely to have heart failure, hypertension, or chronic kidney disease. Lymphopenia was associated with increased risks of mortality (OR = 1.903 [1.389-2.608]; P < 0.001) and pneumonia (OR = 1.510 [1.081-2.111]; P = 0.016), increased LOS (OR = 1.337 [1.217-1.469]; P < 0.001), and likelihood of requiring additional healthcare resources at discharge (OR = 1.669 [1.344-2.073], P < 0.001). Additionally, lymphopenia increased the risk of early in-hospital death (OR = 1.459 [1.097-1.941]; P = 0.009). Subgroup analysis showed that lymphopenia was associated with mortality in polytrauma patients and those who presented with two or more concurrent types of TBI. In all subgroup analyses, lymphopenia was associated with longer length of stay and discharge requiring higher level of care.
CONCLUSION: A routine complete blood count with differential for all TBI patients may help predict patient outcomes and direct care accordingly.
参考来源
- Campbell B, Budreau D, Williams-Perez S, et al. Admission Lymphopenia Predicts Infectious Complications and Mortality in Traumatic Brain Injury Victims. Shock. 2022. PMID: 34618726. doi:10.1097/SHK.0000000000001872
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。